As the marijuana market continues its widespread growth, researchers remain merely at the threshold of exploring the manifold potential medical applications of cannabis.
Cannabis Industry
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targets Specific Diseases with its Proprietary Biotechnologies
Vancouver, Canada-based InMed Pharmaceuticals is a preclinical biotech company that specializes in developing novel drug therapies by manufacturing cannabinoids with the potential to have a therapeutic effect on specific diseases.
Cannabis Companies Demonstrate the Diverse Nature of the Global Marijuana Market
The cannabidiol market is large and diverse; just a few years ago, it was rather small but by 2015, consumer sales had reached $202 million, according to the CBD Report published by The Hemp Business Journal. Cannabidiol sales are expected to grow to over $2 billion by 2020.
DOJA Cannabis Company Provides Production Update
DOJA Cannabis Company Limited (CSE: DOJA) is pleased to announce that we commenced cultivating our first cannabis strains in July and that the plants have taken well to their new home at DOJA's production facility in British Columbia's Okanagan Valley.
CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017
CanniMed Therapeutics Inc. (TSX:CMED)today released its financial results for the three and nine months ended July 31, 2017. Highlights Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017.
This Company Figured Out How to Make CBD from E. Coli
InMed Pharmaceuticals is making bacteria-bred cannabinoids “identical to those found in nature,” sans chemicals or even cannabis.
Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders
Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental health problems.
Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) Oral CBD Product to Be Tested by the University of British Columbia
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has revolutionized oral intake with its TurboCBD™ product.
ChineseInvestors.com, Inc. (CIIX) Sets Goal of Greater than 100% Gain in FY2018 Revenues
ChineseInvestors.com, Inc. (OTCQB: CIIX) recorded a skyrocketing 76% year-over-year operating revenues increase for its fiscal year ended May 31, 2017.
Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders
Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette.
PotNetwork Holding (POTN) Subsidiary Secures More Than $200,000 in Sales at Recent Trade Show
Diamond CBD Sales, a subsidiary of PotNetwork Holding, Inc. (OTC: POTN), attained more than $200,000 in sales at the Big Industry Trade Show in New York on August 10-11.
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Builds Moat around Proprietary Biosynthesis Technology
If you have any doubt that InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) is on the right track as it moves to protect its biosynthesis technology for cannabinoids, then a word from a famed figure may make you change your mind.
At ABcann Global (TSX.V: ABCN) (OTCQB: ABCCF), Medicinal Cannabinoid Quality and Safety are Founding Principles
Ken Clement, the founder of ABcann, with his wealth of experience and knowledge, had observed the variability in consistency and potency of cannabis that was currently available.
SinglePoint, Inc. (SING) Maximizes Upside Potential and Limits Downside Risk
SinglePoint, Inc. (OTC: SING), a publicly traded holding company, offers just such non-traditional upside opportunity with its foray into the burgeoning cannabis market.
Singlepoint, Inc. (SING) CEO Greg Lambrecht Reveals High Points of Convectium Acquisition
There should be “more funding on the way,” according to Singlepoint CEO Greg Lambrecht, who discussed the acquisition in a recent episode of MoneyTV with Donald Baillargeon.